Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA

BACKGROUND: COPD is a major global cause of mortality and morbidity. PINNACLE-4 evaluated the efficacy and safety of GFF MDI (glycopyrrolate/formoterol fumarate metered dose inhaler) in patients from Asia, Europe, and the USA with moderate-to-very severe COPD. METHODS: In this double-blind, placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipworth, Brian J, Collier, David J, Gon, Yasuhiro, Zhong, Nanshan, Nishi, Koichi, Chen, Rongchang, Arora, Samir, Maes, Andrea, Siddiqui, Shahid, Reisner, Colin, Martin, Ubaldo J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167125/
https://www.ncbi.nlm.nih.gov/pubmed/30310273
http://dx.doi.org/10.2147/COPD.S171835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167125/
https://www.ncbi.nlm.nih.gov/pubmed/30310273
http://dx.doi.org/10.2147/COPD.S171835

Ejemplares similares